Clinical Associate Professor Andrew White is a clinician-scientist ophthalmologist at Westmead Hospital. His subspecialty interest is glaucoma. He was awarded First Class Honours in Medical Science in 1995 and a combined MBBS/PhD degree in 2001 from the University of Sydney.
He also undertook research work at the Max Plank Institute for Biophysical Chemistry, Gottingen, Germany and the State University of New York (SUNY). This research focused on the characterisation of the koniocellular visual pathway, responsible for blue-yellow colour vision as well as the physiology behind colour vision and glaucoma detection tests such as perimetry and FDT.
Trained at the Sydney Eye Hospital, he undertook subspecialty training in glaucoma at Westmead Hospital in Sydney and Addenbrooke’s Hospital in Cambridge, UK where he later worked as a Glaucoma Specialist and Senior Lecturer in Ophthalmology at the University of Cambridge. Throughout his time in the UK, Andrew undertook research at the Centre for Brain Repair, University of Cambridge. He has recently been looking at neuroprotective agents to prevent the progression of glaucoma in vitro/ex vivo.
Since his return to Sydney he has been working as a Glaucoma Specialist in private practice and at Westmead Hospital. As a clinician-scientist, Andrew has multiple peer-reviewed scientific publications and published conference abstracts. He is a regular invited speaker at overseas conferences. He is actively involved in the training of medical students, registrars and fellows in cataract and glaucoma. He also lectures optometrists and optometry students in Glaucoma. He is a Clinical Senior Lecturer and has research affiliations with the University of Sydney at both the Save Sight Institute and Westmead Millennium Institute where he has an active laboratory.
Andrew is a member of the Association for Research in Vision and Ophthalmology (ARVO), European Glaucoma Society, Australian and New Zealand Glaucoma Interest Group (ANZGIG). He is an author of the new Asia Pacific Glaucoma Society Guidelines on the management of glaucoma to be published this year. He is a Member of the World Glaucoma Society Associate Advisory Board. He is the current chair of the Glaucoma Australia Expert Advisory Panel. He also chairs the NSW Government Agency for Clinical Innovation C-Eye-C Project looking at new models of health care delivery for chronic eye diseases.
He was the lead author of the RANZCO endorsed guidelines for collaborative management of glaucoma. In addition, he is on the Executive of the Australian Society of Ophthalmologists and is a member of the RANZCO NSW State Branch Committee.